Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
M01ZH09 Vaccine in Healthy Adult Typhoid Challenge Model
NCT01405521Phase 2Completed
- Sponsor
- University of Oxford
- Start
- Oct 2011
- Primary completion
- Dec 2015
- Modality
- Live Attenuated Vaccines
- Countries
- 1
01
Overview
Phase 2, randomised, double-blind trial of M01ZH09 in typhoid fever (3 arms), sponsored by University of Oxford. Primary endpoint: Diagnosis of typhoid fever. Started Oct 2011; status: completed.
02
Drugs
M01ZH09
03
Conditions
typhoid fever
Beyond the preview
Go deeper on NCT01405521.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT01405521.